Video Experimental Relacionado
Updated: Jul 2, 2026
07:10
In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
Un interruptor redox tratable en SHP1 controla la inflamación de los macrófagos
bioRxiv : the preprint server for biology
|February 27, 2026
Resumen
Los investigadores identificaron sitios de cisteína tratables en proteínas inmunes, descubriendo una nueva forma de controlar las respuestas de citoquinas de los macrófagos. Este trabajo abre vías para el desarrollo de productos terapéuticos novedosos dirigidos a la regulación de las células inmunes.
Área de la Ciencia:
- Inmunología
- Bioquímica
- Farmacología
Sus antecedentes:
- Las proteínas inmunológicas son objetivos clave de enfermedades, pero muchas no se han tratado.
- La modificación redox de los residuos de cisteína regula la función de las células inmunes, especialmente las respuestas de citoquinas de los macrófagos.
Objetivo del estudio:
- Desarrollar una estrategia para el descubrimiento y la funcionalización de cisteínas reguladas por redox en proteínas inmunológicas.
- Identificar nuevos sitios de cisteína para el desarrollo de fármacos de moléculas pequeñas dirigidos.
Principales métodos:
- Se utilizó proteómica redox profunda para identificar cisteínas reguladas por redox in vivo.
- Se descubrió y se dirigió un sitio de activación de cisteína novedoso en SHP1.
- Se desarrolló un agonista covalente selectivo (SCA) para dirigirse a Cys102 en SHP1.
Principales resultados:
- Se anotaron 788 cisteínas reguladas por redox in vivo en dominios de proteínas inmunológicamente relevantes.
- Se identificó un sitio de activación de cisteína novedoso en SHP1 (Cys102).
- SCA activó selectivamente SHP1, antagonizando la señalización de IRAK y reduciendo la producción de citoquinas proinflamatorias en macrófagos.
Conclusiones:
- Se identificó un interruptor redox de cisteína tratable que controla las respuestas de citoquinas de los macrófagos.
- Se generó un compendio de sitios regulados por redox para el desarrollo terapéutico.
- Este enfoque permite la farmacología dirigida por cisteína para objetivos inmunológicos.
Videos de Conceptos Relacionados
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:00Cellular Injury I: Introduction
Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...